Jayagopal Ashwath
SEC insider (Form 3/4/5 filer). CIK 0002008983. Chief Scientific & Dev. Ofc. at Opus Genetics, Inc. (IRD). 6 reported Form 4/5 transactions since Sep 2024; latest on Apr 23, 2026. Located in DURHAM, NC.
Companies Jayagopal Ashwath has filed insider reports for
- Opus Genetics, Inc. (IRD): Officer, Chief Scientific & Dev. Ofc.
Jayagopal Ashwath
CIK: 0002008983
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)2 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IRD
Opus Genetics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Apr 23, 2026IRD
Opus Genetics, Inc.
SaleDirect7.5K shares at avg. $5.19$39K - Mar 16, 2026IRD
Opus Genetics, Inc.
SaleDirect3.7K shares at avg. $5.12$19K - Feb 12, 2026IRD
Opus Genetics, Inc.
Tax PaymentDirect5.3K shares at avg. $3.39$18K - Jan 22, 2026IRD
Opus Genetics, Inc.
AwardDirect400K shares- - Mar 13, 2025IRD
Opus Genetics, Inc.
AwardDirect52.5K shares- - Feb 13, 2025IRD
Opus Genetics, Inc.
Tax PaymentDirect5.2K shares at avg. $1.15$6K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 23, 2026 | IRD Opus Genetics, Inc. | Sale | 7,542 | $5.19 | $39,156 | Direct |
| Mar 16, 2026 | IRD Opus Genetics, Inc. | Sale | 3,719 | $5.12 | $19,046 | Direct |
| Feb 12, 2026 | IRD Opus Genetics, Inc. | Tax Payment | 5,313 | $3.39 | $18,011 | Direct |
| Jan 22, 2026 | IRD Opus Genetics, Inc. | Award | 400,000 | - | $0 | Direct |
| Mar 13, 2025 | IRD Opus Genetics, Inc. | Award | 52,500 | - | - | Direct |
| Feb 13, 2025 | IRD Opus Genetics, Inc. | Tax Payment | 5,193 | $1.15 | $5,972 | Direct |
1-6 of 6 transactions